Philipp Harter

32.7k citations
327 papers · 12.3k · 7 hit papers · h-index 50

Impact in

Papers in

    • Ovarian cancer diagnosis and treatment 259
    • Endometriosis Research and Treatment 22
    • PARP inhibition in cancer therapy 73

Philipp Harter

304 papers receiving 12.1k citations

Philipp Harter's Hit Papers

Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up 2023 · 149 citations
1490+5+11Years since publication4008001.2k

Peers

Philipp Harter
Comparison fields: 5 of 128
  • Reproductive Medicine 8.2k
  • Obstetrics and Gynecology 3.4k
  • Oncology 5.3k
  • Surgery 3.6k
  • Cancer Research 1.2k
Replace Mark F. Brady with:
Mark F. Brady United States
Éric Pujade-Lauraine France
Helen Huang United States
Claes G. Tropé Norway
Antonio González-Martı́n Spain
Alexandra Léary France
John A. Blessing United States
Brian N. Bundy United States
Amreen Husain United States
Mansoor Raza Mirza Denmark
Philipp Harter relative to Mark F. Brady United States Mark F. Brady's profile →
Citations per field
00.5×4.3×
Mark F. Brady · 1×
Citations per year

Countries citing papers authored by Philipp Harter

Since Specialization
Citations

This map shows the geographic impact of Philipp Harter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Harter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Harter more than expected).

Fields of papers citing papers by Philipp Harter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Harter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Harter. The network helps show where Philipp Harter may publish in the future.

Co-authors

The 25 scholars most cited alongside Philipp Harter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philipp Harter Line = papers co-authored together Philipp Harter links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 327 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Hit paper breakdown →
20121347
2
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
Hit paper breakdown →
20091132
3
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
Hit paper breakdown →
20141060
4
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial
Hit paper breakdown →
2016309
5
Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Hit paper breakdown →
2022304
6 2006275
7 2012233
8 2017224
9
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
Hit paper breakdown →
2023220
10 2011189
11 2016172
12 2009170
13
Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Hit paper breakdown →
2023149
14 2016148
15 2011145
16 2015128
17 2010126
18 2015121
19 2010115
20 2019114

About Philipp Harter

Philipp Harter is a scholar working on Reproductive Medicine, Oncology, Obstetrics and Gynecology, Surgery and Pulmonary and Respiratory Medicine, having authored 327 papers that have together received 12.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (259 papers), Endometrial and Cervical Cancer Treatments (95 papers), Intraperitoneal and Appendiceal Malignancies (76 papers), PARP inhibition in cancer therapy (73 papers), BRCA gene mutations in cancer (47 papers), Renal cell carcinoma treatment (29 papers), Uterine Myomas and Treatments (25 papers) and Endometriosis Research and Treatment (22 papers). The work is most often cited by research in Reproductive Medicine (8.2k citations), Obstetrics and Gynecology (3.4k citations), Oncology (5.3k citations), Surgery (3.6k citations) and Cancer Research (1.2k citations). Philipp Harter has collaborated with scholars based in Germany, Italy and Belgium. Frequent co-authors include Andreas du Bois, Isabelle Ray‐Coquard, Florian Heitz, Ignace Vergote, Alexander Reuß, Jonathan A. Ledermann, Werner Meier, Jacobus Pfisterer, Ursula A. Matulonis and Michael Friedländer. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Gynecological Cancer, Gynecologic Oncology, Annals of Oncology and Archives of Gynecology and Obstetrics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact